Dr. Jordi Mancebo, director of the Intensive Medicine department of Sant Pau, is coauthor of the survey “Effect of Intravenous Interferon β-1stwhere Death and Days Free From MechanicalVentilation Among Patients With Moderate key Severe Acute Respiratory Distress Syndrome: At Randomized Clinical Trial” published recently at the magazine JAMA, and of which Dr. Antoni J. Betbesé, clinical cape of the same Kick, is member of the multicèntric INTEREST Study Group.
(doi:10.1001/jama.2019.22525)
